Application of liposomes in medicine and drug delivery.

Artif Cells Nanomed Biotechnol

a Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz , Iran.

Published: October 2016

Liposomes provide an established basis for the sustainable development of different commercial products for treatment of medical diseases by the smart delivery of drugs. The industrial applications include the use of liposomes as drug delivery vehicles in medicine, adjuvants in vaccination, signal enhancers/carriers in medical diagnostics and analytical biochemistry, solubilizers for various ingredients as well as support matrices for various ingredients and penetration enhancers in cosmetics. In this review, we summarize the main applications and liposome-based commercial products that are currently used in the medical field.

Download full-text PDF

Source
http://dx.doi.org/10.3109/21691401.2014.953633DOI Listing

Publication Analysis

Top Keywords

drug delivery
8
commercial products
8
application liposomes
4
liposomes medicine
4
medicine drug
4
delivery liposomes
4
liposomes provide
4
provide established
4
established basis
4
basis sustainable
4

Similar Publications

Objectives: Past studies have shown the efficacy of spinal targeted drug delivery (TDD) in pain relief, reduction in opioid use, and cost-effectiveness in long-term management of complex chronic pain. We conducted a survey to determine treatment variables associated with patient satisfaction.

Materials And Methods: Patients in a single pain clinic who were implanted with Medtronic pain pumps to relieve intractable pain were identified from our electronic health record.

View Article and Find Full Text PDF

Ocular surface chemical injuries often result in permanent visual impairment and necessitate complex, long-term treatments. Immediate and extensive irrigation serves as the first-line intervention, followed by various therapeutic protocols applied throughout different stages of the condition. To optimize outcomes, conventional regimens increasingly incorporate biological agents and surgical techniques.

View Article and Find Full Text PDF

Application of biomass carbon dots in food packaging.

Environ Sci Pollut Res Int

January 2025

College of Materials Science and Engineering, Nanjing Forestry University, Nanjing, 210037, China.

Since its discovery, carbon quantum dots (CDs) have been widely applied in cell imaging, drug delivery, biosensing, and photocatalysis due to their excellent water solubility, chemical stability, fluorescence stability biocompatibility, low toxicity, and preparation cost. However, the low fluorescence yield and poor surface structure limit the application of CDs. Heteroatom doping is considered an ideal method to improve CDs' optical and electrical properties.

View Article and Find Full Text PDF

Delayed atorvastatin delivery promotes recovery after experimental spinal cord injury.

Neurotherapeutics

January 2025

Mayo Clinic Graduate School of Biomedical Sciences, Rochester, MN 55905, USA; Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, MN, USA; Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, MN, USA. Electronic address:

Spinal cord injury (SCI) significantly alters gene expression, potentially impeding functional recovery. This study investigated the effects of atorvastatin, a widely prescribed cholesterol-lowering drug, on gene expression and functional recovery in a chronic murine SCI model. Female C57BL/6J mice underwent moderate 0.

View Article and Find Full Text PDF

Design and implication of a breast cancer-targeted drug delivery system utilizing the Kisspeptin/GPR54 system.

Int J Pharm

January 2025

Institute of Biochemistry and Molecular Biology, School of Life Sciences, Lanzhou University, Lanzhou, Gansu 730000, China. Electronic address:

Kisspeptins function as endogenous ligands for the G protein-coupled receptor GPR54. While the primary role of the Kisspeptin/GPR54 signaling pathway pertains to reproduction, several studies have shown that GPR54 is highly expressed in breast cancer, and we further confirmed this result that GPR54 expression is significantly upregulated in breast cancer cells. Based on this finding, we developed a liposomal drug delivery system utilizing the Kisspeptin/GPR54 system to treat breast cancer after confirming the safety of Kp-10-228.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!